Cita APA

Kordes, S., Richel, D. J., Klümpen, H., Weterman, M. J., Stevens, A. J. W. M., & Wilmink, J. W. (2012). A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer. Springer US.

Chicago Style Citation

Kordes, Sil, Dick J. Richel, Heinz-Josef Klümpen, Mariëtte J. Weterman, Arnoldus J. W. M. Stevens, i Johanna W. Wilmink. A Phase I/II, Non-randomized, Feasibility/safety and Efficacy Study of the Combination of Everolimus, Cetuximab and Capecitabine in Patients With Advanced Pancreatic Cancer. Springer US, 2012.

Cita MLA

Kordes, Sil, et al. A Phase I/II, Non-randomized, Feasibility/safety and Efficacy Study of the Combination of Everolimus, Cetuximab and Capecitabine in Patients With Advanced Pancreatic Cancer. Springer US, 2012.